AstraZeneca Results Presentation Deck
November 2024, 157 slides
  1. AstraZeneca
  2. Related Decks
  3. Results Presentation Decks
clinical trials appendix results update | AstraZeneca
pipeline at a glance across five focus therapy areas oncology rare disease | AstraZeneca
key upcoming pipeline catalysts and a ras | AstraZeneca
clinical trials appendix selected highlights | AstraZeneca
project movements since update | AstraZeneca
project movements since update | AstraZeneca
oncology new molecular entity pipeline entity | AstraZeneca
oncology management pipeline management | AstraZeneca
new molecular entity pipeline entity | AstraZeneca
life cycle management pipeline management | AstraZeneca
rare disease pipeline pipeline | AstraZeneca
designations in our pipeline | AstraZeneca
oncology approved medicines and late stage pipeline | AstraZeneca
gastrointestinal cancer | AstraZeneca
lung cancer | AstraZeneca
lung cancer | AstraZeneca
other cancer | AstraZeneca
inhibitor combinations | AstraZeneca
inhibitor other cancer | AstraZeneca
her breast cancer | AstraZeneca
her breast cancer | AstraZeneca
her gastric cancer | AstraZeneca
her other cancers | AstraZeneca
her other cancers | AstraZeneca
her other cancers | AstraZeneca
inhibitor blood cancers | AstraZeneca
met inhibitor and other cancers | AstraZeneca
highly selective irreversible inhibitor | AstraZeneca
highly selective irreversible inhibitor combinations | AstraZeneca
inhibitor breast cancer and prostate cancer a | AstraZeneca
breast cancer | AstraZeneca
| AstraZeneca
| AstraZeneca
| AstraZeneca
other cancers | AstraZeneca
other cancers | AstraZeneca
next generation cell engager malignancies | AstraZeneca
solid | AstraZeneca
next generation oral breast cancer | AstraZeneca
next generation oral breast cancer | AstraZeneca
inhibitor multiple cancers ess | AstraZeneca
solid | AstraZeneca
solid | AstraZeneca
inhibitor solid | AstraZeneca
inhibitor solid | AstraZeneca
solid | AstraZeneca
solid | AstraZeneca
oncology early stage development | AstraZeneca
solid | AstraZeneca
autologous anti and anti car blood cancers anti | AstraZeneca
anti cancer a | AstraZeneca
blood cancers | AstraZeneca
next generation cell engager malignancies ess | AstraZeneca
car solid | AstraZeneca
inhibitor cancer | AstraZeneca
solid | AstraZeneca
solid and blood cancer | AstraZeneca
anti solid ovarian cancer lung cancer top i anti fra a | AstraZeneca
blood cancers | AstraZeneca
car gastrointestinal cancer | AstraZeneca
antibody solid | AstraZeneca
car solid | AstraZeneca
solid | AstraZeneca
inhibitor breast cancer | AstraZeneca
inhibitor solid | AstraZeneca
top i lung cancer | AstraZeneca
top i blood cancers top | AstraZeneca
prostate cancer | AstraZeneca
solid | AstraZeneca
kras specific solid | AstraZeneca
autologous specific targeting solid | AstraZeneca
armored multiple cancers ess | AstraZeneca
solid | AstraZeneca
cancer | AstraZeneca
approved medicines and late stage development | AstraZeneca
anti factor reversal til patients | AstraZeneca
conjugated | AstraZeneca
modulator inhibitor heart failure | AstraZeneca
selective inhibitor hypertension | AstraZeneca
selective inhibitor hypertension | AstraZeneca
| AstraZeneca
eta receptor antagonist inhibitor chronic kidney disease ates til dint | AstraZeneca
eta receptor antagonist inhibitor liver cirrhosis | AstraZeneca
asthma | AstraZeneca
asthma | AstraZeneca
lama asthma | AstraZeneca
lama | AstraZeneca
nasal polyposis and other eosinophilic diseases | AstraZeneca
severe uncontrolled asthma and | AstraZeneca
type i receptor lupus sen nits ats | AstraZeneca
type i receptor sclerosis and other myopathies a | AstraZeneca
and | AstraZeneca
severe uncontrolled asthma | AstraZeneca
next generation propellant | AstraZeneca
next generation propellant | AstraZeneca
| AstraZeneca
| AstraZeneca
severe viral asthma | AstraZeneca
severe viral asthma | AstraZeneca
infection | AstraZeneca
covid | AstraZeneca
covid | AstraZeneca
early stage development | AstraZeneca
dilated | AstraZeneca
inhibitor | AstraZeneca
inhibitor i | AstraZeneca
chronic kidney disease a | AstraZeneca
anti fibrotic mechanism mash | AstraZeneca
mash | AstraZeneca
heart failure | AstraZeneca
inflammation modulator cardiorenal disease | AstraZeneca
oral type diabetes obesity a | AstraZeneca
heart failure | AstraZeneca
long acting amylin obesity with related morbidities til | AstraZeneca
agonist mash a | AstraZeneca
inhibitor cardiovascular disease | AstraZeneca
inhibitor mash | AstraZeneca
flap inhibitor asthma | AstraZeneca
autologous anti and anti car lupus anti pain pais a | AstraZeneca
bronchiectasis | AstraZeneca
See More
AstraZeneca
Results Presentation Decks
Drug Manufacturers—General Decks
Healthcare Decks
Explore Topics
Medicine
Cancer
Recent decks by AstraZeneca
Results
November 2024
Investor Event
September 2024
Results
February 2024
Investor Conference
January 2024
See all presentations by AstraZeneca (30 decks)
Related decks
Exscientia
Results
August 2023
Exscientia
Investor Presentation
October 2023
Nuvectis Pharma
Investor Presentation
December 2023
Exscientia
Results
March 2024
uBiome
Start Up
June 2017
Exscientia
Investor Presentation
March 2024
Nuvectis Pharma
Investor Presentation
July 2023
Exscientia
Investor Presentation
August 2023
Recent decks by AstraZeneca
See all presentations (30 decks)
Results
November 2024
Investor Event
September 2024
Results
February 2024
Investor Conference
January 2024
Exscientia
Results
August 2023
Exscientia
Investor Presentation
October 2023
Nuvectis Pharma
Investor Presentation
December 2023
Exscientia
Results
March 2024
uBiome
Start Up
June 2017
Exscientia
Investor Presentation
March 2024
Nuvectis Pharma
Investor Presentation
July 2023
Exscientia
Investor Presentation
August 2023
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases

Presentations

Start Up
IPO
SPAC
M&A
Investor Day
Results
ESG
Credit
Investment Banking

Explore

Presentation Collections
Slide Collections

Company

Blog
Contact us
© 2021-2024 Slidebook.io